ROCK SPRINGS CAPITAL MANAGEMENT LP Adaptimmune Therapeutics plc Transaction History

ROCK SPRINGS CAPITAL MANAGEMENT LP portfolio value:

$2.53M
portfolio value

ROCK SPRINGS CAPITAL MANAGEMENT LP quarter portfolio value change:

-36.76%
quarter

Adaptimmune Therapeutics plc 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -1.47M $1.08 2.35M
Q2 2022 share Increase +2.63% 60.35K shares -724K $1.7 2.35M
Q1 2022 share Increase +3.68% 81.60K shares -3.57M $2.06 2.29M
Q4 2021 share Increase +1.18% 25.8K shares -3.01M $3.87 2.21M
Q3 2021 share Increase +41.73% 644.78K shares 4.73M $5.17 2.18M
Q2 2021 share 0.00% 0 shares -1.62M $4.26 1.54M
Q1 2021 share 0.00% 0 shares -124K $5.31 1.54M
Q4 2020 share Decrease -22.24% -441.91K shares -7.52M $5.39 1.54M
Q3 2020 share 0.00% 0 shares -4.03M $7.98 1.98M
Q2 2020 share Increase +65.58% 786.91K shares 16.62M $10.01 1.98M
Q1 2020 share Increase +50.00% 400K shares 2.30M $2.72 1.2M
Q4 2019 share Decrease -8.57% -75K shares -361K $1.2 800K
Q3 2019 share 0.00% 0 shares -2.19M $1.51 875K
Q2 2019 share Increase +9.38% 75K shares 78K $4.02 875K
Q1 2019 share Increase +6.67% 50K shares -873K $4.3 800K
Q4 2018 share 0.00% 0 shares -5.85M $5.75 750K
Q3 2018 share 0.00% 0 shares 1.26M $13.56 750K
Q2 2018 share Decrease -14.29% -125K shares -923K $11.87 750K
Q1 2018 share 0.00% 0 shares 3.98M $11.23 875K
Q4 2017 share 0.00% 0 shares -1.32M $6.68 875K
Q3 2017 share 0.00% 0 shares 3.23M $8.19 875K
Q2 2017 share 0.00% 0 shares -892K $4.49 875K
Q1 2017 share Increase +29.63% 200K shares 2.08M $5.51 875K
Q4 2016 share 0.00% 0 shares -2.02M $4.05 675K
Q3 2016 share Decrease -11.76% -90.00K shares -1.47M $7.05 675K
Q2 2016 share 0.00% 0 shares 16K $8.15 765.00K
Q1 2016 share 0.00% 0 shares -3.00M $8.13 765.00K